HIGHLIGHTS
- who: Huan Zhang et al. from the University of Pisa, Italy have published the paper: Exosomes as smart drug delivery vehicles for cancer immunotherapy, in the Journal: (JOURNAL)
- what: The main reason is that the scaling-up process is relatively expensive.
- how: The results indicated that iEXO-OXA promoted the polarization of M2 phenotype to M1 phenotype upon disrupting the combination of galectin-9 and dectin 1 and TME was reprogrammed increasing anti-tumor immunity for pancreatic cancer. The results indicated that DTX-M1-Exo can promote the development of nau00efve macrophages into . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.